Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:171  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1The internal gene duplication and interrupted coding sequences in the MmpL genes of Mycobacterium tuberculosis: Towards understanding the multidrug transport in an evolutionary perspective
Padmani Sandhu,Yusuf Akhter
International Journal of Medical Microbiology.2015;305(3)413
[DOI]
2An unusual/varied presentation of two cases of tuberculous meningitis
MeeraPraful Shah,JitendraD Lakhani,KinjalSatish Patel,VivekN Vaswani
Journal of Integrated Health Sciences.2019;7(2)69
[DOI]
3Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages
Rashmirekha Pati,Rojalin Sahu,Jagannath Panda,Avinash Sonawane
Scientific Reports.2016;6(1)69
[DOI]
4Platinum(II)-azoimidazole drugs against TB and cancer: Structural studies, cytotoxicity and anti-mycobacterial activity
Chandana Sen,Chiranjit Patra,Sudipa Mondol,Amitabha Datta,Debashis Mallick,Tapan Kumar Mondal,Tulin Askun,Pinar Celikboyun,Zerrin Cantürk,Chittaranjan Sinha
Polyhedron.2018;152(1)1
[DOI]
5Determinants of delayed tuberculosis treatment among patients in Selangor: A study protocol
Punitha Makeswaran,Shamsul Azhar Shah,Nazarudin Safian,Nor Asiah Muhamad,Abdul Aziz Harith,Seyed Ehtesham Hasnain
PLOS ONE.2022;17(4)e0266746
[DOI]
6Copper mediated one-pot synthesis of quinazolinones and exploration of piperazine linked quinazoline derivatives as anti-mycobacterial agents
Satyaveni Malasala,Jitendra Gour,Md. Naiyaz Ahmad,Srikanth Gatadi,Manjulika Shukla,Grace Kaul,Arunava Dasgupta,Y. V. Madhavi,Sidharth Chopra,Srinivas Nanduri
RSC Advances.2020;10(71)43533
[DOI]
7Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of Mycobacterium tuberculosis in Ghana
Enid Owusu,Mercy Jemima Newman
Medical Sciences.2020;8(1)5
[DOI]
8Health-related quality of life among tuberculosis patients under Revised National Tuberculosis Control Programme in rural and urban Puducherry
S. Ramkumar,S. Vijayalakshmi,N. Seetharaman,R. Pajanivel,A. Lokeshmaran
Indian Journal of Tuberculosis.2017;64(1)14
[DOI]
9Quercetin Loaded Rifampicin-Floating Microspheres for Improved Stability and In-vitro Drug Release
Prashant Lakshaman Pingale,Sunil Vishwanath Amrutkar
Pharmacophore.2021;12(3)95
[DOI]
10Endothelial lineage-specific interaction of Mycobacterium tuberculosis with the blood and lymphatic systems
Paul M. Kim,Jae-Jin Lee,Dongwon Choi,Hyungjin Eoh,Young-Kwon Hong
Tuberculosis.2018;111(3)1
[DOI]
11Burgeoning double burden of tuberculosis and diabetes in India: Magnitude of the problem – Strategies and solutions
Preety Sharma,Fehmida Visnegarwala,Vinay Tripathi
Clinical Epidemiology and Global Health.2014;2(3)107
[DOI]
12Modeling and analysis of barriers in controlling TB: developing countries' perspective
Palka Mittal,Puneeta Ajmera,Vineet Jain,Gaurav Aggarwal
International Journal of Health Governance.2021;26(4)362
[DOI]
13Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis
Premashis Kar,Rahul Karna,Rajesh Ruttala,Shilpa Arora,Anita Chakravarty,Suresh Kumar
Journal of Clinical and Experimental Hepatology.2019;9(2)200
[DOI]
14Prevalencia de la sintomatología respiratoria en trabajadores mineros del municipio de Socotá, Boyacá, 2017
Nelson Camilo Gutiérrez-Alvarado
Revista Investigación en Salud Universidad de Boyacá.2018;5(1)99
[DOI]
15Molecular detection of Mycobacterium tuberculosis in cattle and buffaloes: a cause for public health concern
Khaled A. Abdel-Moein,Osman Hamed,Heba Fouad
Tropical Animal Health and Production.2016;48(8)1541
[DOI]
16

Factors Affecting Tuberculosis Patients’ Quality of Life in Surabaya, Indonesia

Ni Njoman Juliasih,Ni Made Mertaniasih,Cholichul Hadi,. Soedarsono,Reny Mareta Sari,Ilham Nur Alfian
Journal of Multidisciplinary Healthcare.2020;Volume 13(8)1475
[DOI]
17Design, synthesis, and characterization of novel substituted 1,2,4-oxadiazole and their biological broadcast
Paranjay H. Parikh,Jignesh B. Timaniya,Mrugesh J. Patel,Kaushal P. Patel
Medicinal Chemistry Research.2020;29(3)538
[DOI]
18Design, synthesis, and characterization of novel substituted 1,2,4-oxadiazole and their biological broadcast
Sarita Rani,Ankur Kaul,Anil Kumar Mishra,Umesh Gupta
Medicinal Chemistry Research.2021;29(3)91
[DOI]
19Novel In Silico Insights into Rv1417 and Rv2617c as Potential Protein Targets: The Importance of the Medium on the Structural Interactions with Exported Repetitive Protein (Erp) of Mycobacterium tuberculosis
Margot Paco-Chipana,Camilo Febres-Molina,Jorge Alberto Aguilar-Pineda,Badhin Gómez
Polymers.2022;14(13)2577
[DOI]
20Isoniazid–phytochemical conjugation: A new approach for potent and less toxic anti-TB drug development
Shasank S. Swain,Sudhir K. Paidesetty,Rabindra N. Padhy,Tahziba Hussain
Chemical Biology & Drug Design.2020;96(2)714
[DOI]
21Molecular Epidemiology of Mycobacteriosis in Wildlife and Pet Animals
Mark D. Schrenzel
Veterinary Clinics of North America: Exotic Animal Practice.2012;15(1)1
[DOI]
22SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study
Georges Bediang,Beat Stoll,Nadia Elia,Jean-Louis Abena,Désiré Nolna,Philippe Chastonay,Antoine Geissbuhler
Trials.2014;15(1)1
[DOI]
23Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia
Melaku Tilahun,Ezra Shimelis,Teklu Wogayehu,Gebeyehu Assefa,Getachew Wondimagegn,Alemayehu Mekonnen,Tsegaye Hailu,Kidist Bobosha,Abraham Aseffa,Hasnain Seyed Ehtesham
PLOS ONE.2020;15(8)e0236054
[DOI]
24Computational exploration and anti-mycobacterial activity of potential inhibitors of Mycobacterium tuberculosis acetyl coenzyme A carboxylase as anti-tubercular agents
J. Kuldeep,S.K. Sharma,B.N. Singh,M.I. Siddiqi
SAR and QSAR in Environmental Research.2021;32(3)191
[DOI]
25In-vitro Anti-Tuberculosis, Anti-Efflux Pumps and Anti-Biofilm Effects of Crinum Asiaticum Bulbs
Michael Ofori,Cynthia Amaning Danquah,Selase Ativui,Peace Doe,Williams Adu Asamoah
Biomedical and Pharmacology Journal.2021;14(4)1905
[DOI]
26Anti-mycobacterial activity of heat and pH stable high molecular weight protein(s) secreted by a bacterial laboratory contaminant
Md. Sajid Hussain,Atul Vashist,Mahadevan Kumar,Neetu Kumra Taneja,Uma Shankar Gautam,Seema Dwivedi,Jaya Sivaswami Tyagi,Rajesh Kumar Gupta
Microbial Cell Factories.2022;21(1)1905
[DOI]
27Interaction of Host Pattern Recognition Receptors (PRRs) with Mycobacterium Tuberculosis and Ayurvedic Management of Tuberculosis: A Systemic Approach
Nirmaladevi Ponnusamy,Mohanapriya Arumugam
Infectious Disorders - Drug Targets.2022;22(2)1905
[DOI]
28The Clean India Mission: Public and animal health benefits
Rashmi Thakur,Balbir Bagicha Singh,Prateek Jindal,Rabinder Singh Aulakh,Jatinder Paul Singh Gill
Acta Tropica.2018;186(2)5
[DOI]
29Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: a systematic review and meta-analysis
Hyunsuk Frank Roh,Jihoon Kim,Seung Hyuk Nam,Jung Mogg Kim
European Journal of Cardio-Thoracic Surgery.2017;52(4)673
[DOI]
30A Rare Case of Tuberculosis Cutis Colliquative
Shravya Rimmalapudi,Amruta D. Morey,Bhushan Madke,Adarsh Lata Singh,Sugat Jawade
Journal of Evolution of Medical and Dental Sciences.2021;10(5)305
[DOI]
31Nanotechnology based anti-infectives to fight microbial intrusions
M. Rai,A.P. Ingle,S. Gaikwad,I. Gupta,A. Gade,S. Silvério da Silva
Journal of Applied Microbiology.2016;120(3)527
[DOI]
32Nanotechnology based anti-infectives to fight microbial intrusions
Agnieszka M. Frydrych,Camile S. Farah
Journal of Applied Microbiology.2018;120(3)1
[DOI]
33Use of classification and regression tree (CART), to identify hemoglobin A1C (HbA 1C ) cut-off thresholds predictive of poor tuberculosis treatment outcomes and associated risk factors
Josephine W. Mburu,Leonard Kingwara,Magiri Ester,Nyerere Andrew
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2018;11(3)10
[DOI]
34Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
Vivek Viswanathan,Rajesh Pharande,Anilkumar Bannalikar,Pushpa Gupta,Umesh Gupta,Alka Mukne
Drug Development and Industrial Pharmacy.2019;45(1)11
[DOI]
35Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
Madhumanti Mondal,Atmaram Pawar,Kaustuv Sahoo,Dileep Kumar
Drug Development and Industrial Pharmacy.2021;45(1)169
[DOI]
36Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
Wanisa Salaemae,Grant W. Booker,Steven W. Polyak
Drug Development and Industrial Pharmacy.2016;45(1)797
[DOI]
37Bedaquiline: A Mini Review
Nandhini Saravanabavan,Padmavathi Shanmuganathan,Manimekalai Kumarappan
Annals of SBV.2020;8(1)2
[DOI]
38Paradigm shift in efforts to end TB by 2025
K.S. Sachdeva,Malik Parmar,Raghuram Rao,Sandeep Chauhan,Vaibhav Shah,Ra Pirabu,Deepak Balasubramaniam,Bhavin Vadera,S. Anand,Manu Mathew,Hardik Solanki,V.V. Sundar
Indian Journal of Tuberculosis.2020;67(4)S48
[DOI]
39Computational design of MmpL3 inhibitors for tuberculosis therapy
R. Chaitra,Rohit Gandhi,N. Jayanna,Sachin Satyanath,Parasuraman Pavadai,Manikanta Murahari
Molecular Diversity.2022;67(4)S48
[DOI]
40Scenario of Tuberculosis in India
Jyoti Priyadarshini Shrivastava,Alok Shrivastava
Journal of Lung, Pulmonary & Respiratory Research.2021;8(2)24
[DOI]
41Scenario of Tuberculosis in India
Agnieszka M. Frydrych,Camile S. Farah
Journal of Lung, Pulmonary & Respiratory Research.2018;8(2)1
[DOI]
42Analysis of CD4 and CD8 expression in multidrug-resistant tuberculosis infection with diabetes mellitus: An experimental study in mice
Heidy Agustin,Muhammad Nasrum Massi,Irawati Djaharuddin,Agus Dwi Susanto,Andi Asadul Islam,Mochammad Hatta,Agussalim Bukhari,Nur Ahmad Tabri,Arif Santoso,Ilhamjaya Patellongi
Annals of Medicine and Surgery.2021;68(2)102596
[DOI]
43Long-term exposure to indoor air pollution and risk of tuberculosis
Vidhiben Patel,Andrew Foster,Alison Salem,Amit Kumar,Vineet Kumar,Biplab Biswas,Mehdi Mirsaeidi,Naresh Kumar
Indoor Air.2021;31(3)628
[DOI]
44Drug development against tuberculosis: Impact of alkaloids
Shardendu K. Mishra,Garima Tripathi,Navneet Kishore,Rakesh K. Singh,Archana Singh,Vinod K. Tiwari
European Journal of Medicinal Chemistry.2017;137(3)504
[DOI]
45Mitigating the externality of diseases of poverty through health aid
Kamal Jnawali,Michael G. Tyshenko,Tamer Oraby
Royal Society Open Science.2021;8(10)504
[DOI]
46SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial
Georges Bediang,Beat Stoll,Nadia Elia,Jean-Louis Abena,Antoine Geissbuhler
BMC Public Health.2018;18(1)504
[DOI]
472 Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy for Targeted Therapy of Tuberculosis
Pratiksha Prabhu,Trinette Fernandes,Mansi Damani,Pramila Chaubey,Shridhar Narayanan,Sujata Sawarkar
Current Drug Delivery.2022;19(8)830
[DOI]
482 Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy for Targeted Therapy of Tuberculosis
Agnieszka M. Frydrych,Camile S. Farah
Current Drug Delivery.2019;19(8)871
[DOI]
49Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis
Huicong Liu,Min Yang,Zheng-Guo He
Scientific Reports.2016;6(1)871
[DOI]
50Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcare
Remya Nambiar,Daksha Shah,Kanchan Ajbani,Mubin Kazi,Meeta Sadani,Anjali Shetty,Padmaja Keskar,Sanjeev Kamble,Alex van Belkum,Camilla Rodrigues
Tuberculosis.2018;110(1)86
[DOI]
51Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya
Collins Otieno Ogari,Anthony Kebira Nyamache,James Nonoh,Evans Amukoye
BMC Infectious Diseases.2019;19(1)86
[DOI]
52Pharmacovigilance and Public Health Ethics
Torbjörn Callréus
Pharmaceutical Medicine.2013;27(3)157
[DOI]
53The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis
Basant Joshi,Trisasi Lestari,Stephen Michael Graham,Sushil Chandra Baral,Sharat Chandra Verma,Gokarna Ghimire,Bandana Bhatta,Shyam Prakash Dumre,Adi Utarini,Seyed Ehtesham Hasnain
PLOS ONE.2018;13(8)e0201731
[DOI]
54The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents
Matthew R. Bockman,Neeraj Mishra,Courtney C. Aldrich
Current Medicinal Chemistry.2020;27(25)4194
[DOI]
55Hybrid PET/MRI findings in a case of pulmonary and extra-pulmonary tuberculosis associated with motor-neuron disease-like illness—a coincidence or a causation?: a case report
Sameer Peer,Chandana Nagaraj,Sandhya Mangalore
Egyptian Journal of Radiology and Nuclear Medicine.2021;52(1)4194
[DOI]
56Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: A molecular docking and molecular dynamics simulation study
Sravan Kumar Miryala,Soumya Basu,Aniket Naha,Reetika Debroy,Sudha Ramaiah,Anand Anbarasu,Saravanan Natarajan
Journal of Molecular Liquids.2021;341(1)117340
[DOI]
57Studies on new substituted pyridazinones: synthesis and biological evaluation
Mohammad Asif,Anita Singh,Shah Alam Khan,Asif Husain
Brazilian Journal of Pharmaceutical Sciences.2018;54(3)117340
[DOI]
58Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects
Chen Bing,Cao Xiaomeia,Li Jinhenga
Drug Metabolism and Drug Interactions.2011;26(3)117340
[DOI]
59Risk Factors of Tuberculosis Infection Among HIV/AIDS Patients in Burkina Faso
Ziemlé Clément Méda,Issiaka Sombié,Olivier W.C. Sanon,Daouda Maré,Donald E. Morisky,Yi-Ming Arthur Chen
AIDS Research and Human Retroviruses.2013;29(7)1045
[DOI]
60Treatment of Tuberculosis using Ethno-medicinal Plants of Amarkantak Region
Ram Sewak Kach,Vikas Kumar Sake,Poonam Sharma,Pranveer Singh
Asian Journal of Animal and Veterinary Advances.2017;13(1)52
[DOI]
61Is Mycobacterium tuberculosis carcinogenic to humans?
Deodutta Roy,Nasreen Z. Ehtesham,Seyed Ehtesham Hasnain
The FASEB Journal.2021;35(9)52
[DOI]
62Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS
Thomas Isaiah Sudarsan,Lovely Thomas,Abhishek Samprathi,Binila Chacko,Alice Mathuram,Tina George,Gunasekaran Karthik,Sudha Jasmine Rajan,Ronald Albert Benton Carey,Gowri Mahasampath,John Victor Peter
Journal of Critical Care.2021;61(9)138
[DOI]
63Prevalence, diagnosis, management and control of important diseases of ruminants with special reference to indian scenario
Mani Saminathan,Rajneesh Rana,Muthannan Andavar Ramakrishnan,Kumaragurubaran Karthik,Yashpal Singh Malik,Kuldeep Dhama
Journal of Experimental Biology and Agricultural Sciences.2016;4(3S)338
[DOI]
64Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach
Ajit Kumar,Priyanka Sharma,Akanksha Arun,Laxman S. Meena
Journal of Biomolecular Structure and Dynamics.2022;4(3S)1
[DOI]
65Tendência e caracterização epidemiológica da tuberculose em Alagoas, 2007-2016
Clodis Maria Tavares,Amanda Maria Silva da Cunha,Nataly Mayara Cavalcante Gomes,Ana Beatriz de Almeida Lima,Igor Michel Ramos dos Santos,Mileyse da Silva Acácio,Daniella Marques dos Santos,Carlos Dornels Freire de Souza
Cadernos Saúde Coletiva.2020;28(1)107
[DOI]
66ISONIAZID MONORESISTANCE : THE NEW CHALLENGE IN DRUG RESISTANT TUBERCULOSIS
Paulami Palchowdhury,Anindita Rakshit,Aitihya Chakraborty,Banya Chakraborty
INDIAN JOURNAL OF APPLIED RESEARCH.2021;28(1)38
[DOI]
67Piperonal: The Journey so Far
Jain Akash,Chaudhary Dushyant,Chaudhary Jasmine
Mini-Reviews in Medicinal Chemistry.2020;20(18)1846
[DOI]
68Identification of novel selective Mtb -DHFR inhibitors as antitubercular agents through structure-based computational techniques
Kalicharan Sharma,Nazia Neshat,Shweta Sharma,Namita Giri,Apeksha Srivastava,Faisal Almalki,Khalid Saifullah,Md. Mumtaz Alam,Mohammad Shaquiquzzaman,Mymoona Akhter
Archiv der Pharmazie.2020;353(2)1900287
[DOI]
69Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis
Satyaveni Malasala,Md Naiyaz Ahmad,Ravikumar Akunuri,Manjulika Shukla,Grace Kaul,Arunava Dasgupta,Y.V. Madhavi,Sidharth Chopra,Srinivas Nanduri
European Journal of Medicinal Chemistry.2021;212(2)112996
[DOI]
70Direct detection of rpoB and katG gene mutations of Mycobacterium tuberculosis in clinical samples
Sunil Pandey,Ashima Lamichhane,Anu Byanjankar,Ansuma Kharel,Chandrakala Rai,Sunil Prasad Lekhak,Menuka Karki
Asian Pacific Journal of Tropical Biomedicine.2017;7(8)698
[DOI]
71Ethnobotanical study of selected medicinal plants traditionally used in the rural Greater Mpigi region of Uganda
Fabien Schultz,Godwin Anywar,Barbara Wack,Cassandra Leah Quave,Leif-Alexander Garbe
Journal of Ethnopharmacology.2020;256(8)112742
[DOI]
72TO SEE THE IMPACT OF LOCKDOWN IN COVID19 PANDEMIC ON TUBERCULAR PATIENTS IN A TERTIARY CARE CENTRE OF HILLY AREA.
Subhash Chander,Ritin Sharma,Ankit Chaudhary,Rakesh Chauhan
INDIAN JOURNAL OF APPLIED RESEARCH.2020;256(8)33
[DOI]
73Need-based training of community health officers for tuberculosis care in Ahmednagar district of Maharashtra, India: A before and after study
MandarPadmakar Baviskar,Ankita Sinha,ShubhadaS Javadekar,Rajvir Bhalwar
Journal of Education and Health Promotion.2021;10(1)322
[DOI]
74Sulfonamide derivatives as Mycobacterium tuberculosis inhibitors: in silico approach
Sayantan Pradhan,Chittaranjan Sinha
In Silico Pharmacology.2018;6(1)322
[DOI]
75Anti-mycobacterial activity of labdane and halimane diterpenes obtained from Plectranthus ornatus Codd
Joana M. Andrade,Alessandra Romagnoli,Joana F. Almeida,Inês M. Ferreira,Catarina Garcia,Ana Díaz-Lanza,Gian Maria Fimia,Patrícia Rijo
Journal Biomedical and Biopharmaceutical Research.2018;15(1)101
[DOI]
76Squamous Cell Carcinoma in the Post Tuberculosis Lung after 30 Years of Treatment Completion
Arulprashanth Arulanantham,Umesh Jayarajah,Rohitha Dharmasiri,Rasarathinam Jeyanthakumar,Kamila Niroshan Siriwardena,Sujeewa Ilangamge
Case Reports in Surgery.2020;2020(1)1
[DOI]
77Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection
Rustin R Lovewell,Christopher M Sassetti,Brian C VanderVen
Current Opinion in Microbiology.2016;29(1)30
[DOI]
78Doctors' compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China
Xiaofei Zheng,Fangying Zhong,Xinping Zhang
Journal of Evaluation in Clinical Practice.2014;20(3)288
[DOI]
79An Inclusive Perception on Pathogenesis, Epidemiology and Risk Factors Associated With Mycobacterium tuberculosis
Manish Dwivedi,Mahima Bhat,Aiswarya Radha Krishnan
Current Respiratory Medicine Reviews.2022;18(3)190
[DOI]
80Association of IRGM promoter region polymorphisms and haplotype with pulmonary tuberculosis in Pakistani (Punjab) population
Ayesha Zafar,Mohsin Shafiq,Basharat Ali,Wolfgang Sadee,Abdul Rauf Shakoori,Farah Rauf Shakoori
Tuberculosis.2022;136(3)102233
[DOI]
81QSAR based therapeutic management of M. tuberculosis
Shahzaib Ahamad,Safikur Rahman,Faez Iqbal Khan,Neeraja Dwivedi,Sher Ali,Jihoe Kim,Md. Imtaiyaz Hassan
Archives of Pharmacal Research.2017;40(6)676
[DOI]
82QSAR based therapeutic management of M. tuberculosis
Ravi Bhushan,Sonal Upadhyay,Mithun Rudrapal
Archives of Pharmacal Research.2022;40(6)289
[DOI]
83Analysis of CTLA-4 (+49A/G) Gene Polymorphism and the Risk of Tuberculosis in Southeast of Iran
Edris Paad,Mohammad Kordi Tamendani,Mohammad Hosain Sangtarash,Mansoor Dehvari
Gene, Cell and Tissue.2014;1(3)289
[DOI]
84AN INSIGHT INTO PRIVILEGED SCAFFOLDS IN TUBERCULOSIS: DEVELOPMENTAL ASPECTS AND IMPLICATIONS IN DRUG DESIGN
Rani. A. Shinde,Vasanti. M. Suvarna,Arundhati. N. Abhyankar
Indian Drugs.2022;59(01)7
[DOI]
85Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents
Satyaveni Malasala,Md Naiyaz Ahmad,Jitendra Gour,Manjulika Shukla,Grace Kaul,Abdul Akhir,Srikanth Gatadi,Y.V. Madhavi,Sidharth Chopra,Srinivas Nanduri
Journal of Molecular Structure.2020;1218(01)128493
[DOI]
86Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents
Daljeet S. Dhanjal,Meenu Mehta,Chirag Chopra,Reena Singh,Parvarish Sharma,Dinesh K. Chellappan,Murtaza M. Tambuwala,Hamid A. Bakshi,Alaa A.A. Aljabali,Gaurav Gupta,Srinivas Nammi,Parteek Prasher,Kamal Dua,Saurabh Satija
Journal of Molecular Structure.2021;1218(01)253
[DOI]
87Gene silencing by CRISPR interference in mycobacteria
Eira Choudhary,Preeti Thakur,Madhu Pareek,Nisheeth Agarwal
Nature Communications.2015;6(1)253
[DOI]
88Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population
Bing Chen,Hao-Qiang Shi,Meihua Rose Feng,Xi-Han Wang,Xiao-Mei Cao,Wei-Min Cai
Frontiers in Pharmacology.2022;13(1)253
[DOI]
89Incidence of mycobacterial disorders in Indian adult male service population followed for over two decades
Hari K.V.S. Kumar,Saroj K. Patnaik
Journal of Infection and Public Health.2018;11(4)581
[DOI]
90Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward
Mainak Bardhan,Mohammad Mehedi Hasan,Ishita Ray,Anusua Sarkar,Priyanka Chahal,Sudhan Rackimuthu,Mohammad Yasir Essar
Tropical Medicine and Health.2021;49(1)581
[DOI]
91The Role of Biotin in Bacterial Physiology and Virulence: a Novel Antibiotic Target for Mycobacterium tuberculosis
Wanisa Salaemae,Grant W. Booker,Steven W. Polyak,Indira T. Kudva,Bryan H. Bellaire
Microbiology Spectrum.2016;4(2)581
[DOI]
92Vernonia adoensisLeaf Extracts Cause Cellular Membrane Disruption and Nucleic Acid Leakage inMycobacterium smegmatis
Ruvimbo Mautsa,Stanley Mukanganyama
Journal of Biologically Active Products from Nature.2017;7(2)140
[DOI]
93“TUBERCULOSIS – A COMMON GRANULOMATOUS DISEASE AT UNCOMMON SITES: A COMPREHENSIVE HISTOCYTOLOGICAL STUDY IN A TERTIARY CARE HOSPITAL OF CENTRAL INDIA”
Anki Saluja,Rashmi Gupta,Chitrangi P. Barpande,B. P. Singh
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021;7(2)65
[DOI]
94Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and Anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study
Navin B. Patel,Asif R. Shaikh,Vatsal M. Patel,Edgar E. Lara-Ramirez,Gildardo Rivera
Letters in Drug Design & Discovery.2019;16(4)382
[DOI]
95Bactericidal Potency and Extended Serum Life of Stereo-Chemically Engineered Peptides Against Mycobacterium
Prakash Kishore Hazam,Anjali Singh,Nitin Chaudhary,Vibin Ramakrishnan
International Journal of Peptide Research and Therapeutics.2019;25(2)465
[DOI]
96Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic
Aditya Narayan Konwar,Vivek Borse
Sensors International.2020;1(2)100015
[DOI]
97Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery
Mayuri S. Prasad,Ritesh P. Bhole,Pramod B. Khedekar,Rupesh V. Chikhale
Bioorganic Chemistry.2021;115(2)105242
[DOI]
98Prediction of Antitubercular Peptides From Sequence Information Using Ensemble Classifier and Hybrid Features
Salman Sadullah Usmani,Sherry Bhalla,Gajendra P. S. Raghava
Frontiers in Pharmacology.2018;9(2)105242
[DOI]
99Status and challenges for tuberculosis control in India – Stakeholders' perspective
Gargi Thakur,Shalvi Thakur,Harshad Thakur
Indian Journal of Tuberculosis.2021;68(3)334
[DOI]
100Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment
Gokul Raj Kathamuthu,Kadar Moideen,Nathella Pavan Kumar,Rathinam Sridhar,Dhanaraj Baskaran,Subash Babu,Martin E. Rottenberg
PLOS ONE.2020;15(5)e0233426
[DOI]
101Contribution of community pharmacy in treating tuberculosis: A pharmacy centric study from Belagavi district
UdayKumar Rangaswamy,MadiwalayyaS Ganachari
Journal of Reports in Pharmaceutical Sciences.2020;9(2)246
[DOI]
102State Feedback and Synergetic controllers for tuberculosis in infected population
Muhammad Bilal,Iftikhar Ahmad,Sheraz Ahmad Babar,Khurram Shahzad
IET Systems Biology.2021;15(3)83
[DOI]
103One-step preparation of N-doped grapheme quantum dots with high quantum yield for bioimaging and highly sensitive electrochemical detection of isoniazid
S. Sivaselvam,C. Viswanathan,N. Ponpandian
Biomaterials Advances.2022;135(3)212731
[DOI]
104Breast Tuberculosis: A Report of Two Cases
Meghraj Kundan,Puthangot Aswin,Garima Tyagi,Mainak Ghosh
International Journal of Infection.2022;9(3)212731
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008